Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is -20.23% vs 10.88% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is 386.67% vs -54.55% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023
Compare Quarterly Results Of Lincoln Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2024 is -9.09% vs 9.46% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2024 is -21.12% vs 11.24% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2024 is -16.60% vs 24.81% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -20.23% vs 10.88% in Dec 2023
Quarterly - Interest
QoQ Growth in quarter ended Dec 2024 is 108.57% vs -20.45% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 386.67% vs -54.55% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023